期刊
CIRCULATION
卷 120, 期 25, 页码 2567-2576出版社
LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1161/CIRCULATIONAHA.109.898445
关键词
atherosclerosis; endothelium; estrogens; hormones; receptors
资金
- INSERM
- Universite de Toulouse and Faculte de Medecine Toulouse-Rangueil
- European Vascular Genomics Network
- Agence Nationale pour la Recherche
- Conseil Regional Midi-Pyrenees and Aquitaine
- Societe Francaise d'Hypertension Arterielle
- Fondation pour la Recherche Medicale
- Societe et Federation Francaise de Cardiologie
- Fondation Coeur et Arteres
- Association pour la Recherche sur la Sclerose en Plaques
Background-The prevention of early atheroma by estrogens has been clearly demonstrated in all animal models and appears to be mediated through a direct action on the arterial wall rather than through an effect on the lipoprotein profile. The goal of the present study was to evaluate which cellular target is crucial in this beneficial action of estradiol. Methods and Results-We first confirmed the key role of estrogen receptor-alpha (ER alpha) in the atheroprotective effect of estradiol, because this action was completely abolished in mice deficient in both the low-density lipoprotein receptor (LDLr) and ER alpha. Second, using chimeric mice with an ER alpha deficiency in the hematopoietic lineage, we showed the persistence of the protective action of estradiol, which suggests the involvement of extrahematopoietic ER alpha. Third, we showed that loxP-flanked ER alpha mice (ER alpha(flox/flox)) bred with Tie2-Cre(+) mice on an LDLr-/- background had complete inactivation of ER alpha in most hematopoietic and all endothelial cells. Remarkably, in this mouse model, the atheroprotective effect of estradiol was completely abolished. Fourth, the atheroprotective effect of estradiol remained abolished in Tie2-Cre(+) ER alpha(flox/flox) LDLr-/- mice transplanted with either Tie2-Cre(+) ER alpha(flox/flox) or ER alpha(-/-) bone marrow, whereas it was present in analogous chimeric Tie2-Cre(-) ER alpha(flox/flox) LDLr-/- receivers expressing endothelial ER alpha. Conclusions-We demonstrate directly and for the first time that endothelial ER alpha represents a key target of the atheroprotective effect of estradiol, whereas hematopoietic ER alpha is dispensable. Selective estrogen receptor modulators that mimic the endothelial action of estradiol should now be considered in atheroprotection. (Circulation. 2009;120:2567-2576.)
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据